person · Reporting owner
Schoenherr Thomas Edward
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Tempus AI, Inc.TEM · Entity 1545 | CEO, Diagnostics | September 25, 2026 | September 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Tempus AI, Inc.
Report date September 25, 2026 · Filed September 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 76,740 |
Reported balance
After 2026-09-25 transaction · row 1
1 source rowRow 1 · 2026-09-25 · Sale · Disposed 10,281 · Balance 76,740 F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 25, 2026 Filed Sep 29, 2026 20:15 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 10,281 | $85.00 | $873,885.00 |
DisclosureSEC source: 0002113721-26-000018 · form4-09292026_040901.xml · nonDerivative · entry 1 Schoenherr Thomas Edward · CIK 0002113721 · CEO, Diagnostics 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,740 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 20:15 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 2,694 | $70.00 | $188,580.00 |
DisclosureSEC source: 0002113721-26-000016 · form4-08252026_040805.xml · nonDerivative · entry 1 Schoenherr Thomas Edward · CIK 0002113721 · CEO, Diagnostics 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 87,021 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 01:00 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 494 | $61.23 | $30,247.62 |
DisclosureSEC source: 0002113721-26-000014 · form4-08202026_090811.xml · nonDerivative · entry 7 Schoenherr Thomas Edward · CIK 0002113721 · CEO, Diagnostics 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,715 F3 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. F8 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.16 to $61.25 inclusive. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 01:00 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 900 | $60.45 | $54,405.00 |
DisclosureSEC source: 0002113721-26-000014 · form4-08202026_090811.xml · nonDerivative · entry 6 Schoenherr Thomas Edward · CIK 0002113721 · CEO, Diagnostics 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 90,209 F3 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.08 to $60.77 inclusive. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 01:00 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 2,994 | $59.97 | $179,550.18 |
DisclosureSEC source: 0002113721-26-000014 · form4-08202026_090811.xml · nonDerivative · entry 5 Schoenherr Thomas Edward · CIK 0002113721 · CEO, Diagnostics 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 91,109 F3 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.05 to $60.04 inclusive. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 01:00 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 500 | $57.94 | $28,970.00 |
DisclosureSEC source: 0002113721-26-000014 · form4-08202026_090811.xml · nonDerivative · entry 4 Schoenherr Thomas Edward · CIK 0002113721 · CEO, Diagnostics 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,103 F3 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.51 to $58.26 inclusive. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 01:00 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 100 | $56.47 | $5,647.00 |
DisclosureSEC source: 0002113721-26-000014 · form4-08202026_090811.xml · nonDerivative · entry 3 Schoenherr Thomas Edward · CIK 0002113721 · CEO, Diagnostics 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,603 F3 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 01:00 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 3,094 | $55.97 | $173,171.18 |
DisclosureSEC source: 0002113721-26-000014 · form4-08202026_090811.xml · nonDerivative · entry 2 Schoenherr Thomas Edward · CIK 0002113721 · CEO, Diagnostics 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,703 F3 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.38 to $56.01 inclusive. Read SEC document |
| August 18, 2026 Filed Aug 21, 2026 01:00 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 9,232 | $49.61 | $457,999.52 |
DisclosureSEC source: 0002113721-26-000014 · form4-08202026_090811.xml · nonDerivative · entry 1 Schoenherr Thomas Edward · CIK 0002113721 · CEO, Diagnostics 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,797 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.35 to $49.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8). Read SEC document |
| May 19, 2026 Filed May 21, 2026 21:05 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 1,580 | $44.07 | $69,630.60 |
DisclosureSEC source: 0002113721-26-000009 · form4-05212026_050511.xml · nonDerivative · entry 1 Schoenherr Thomas Edward · CIK 0002113721 · CEO, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,029 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.65 to $44.46 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 6, 2026 20:30 UTC | Tempus AI, Inc. TEM · Entity 1545 | GrantClass A Common Stock | 13,642 | $0.00 | $0.00 |
DisclosureSEC source: 0002113721-26-000004 · form4-05062026_040510.xml · nonDerivative · entry 1 Schoenherr Thomas Edward · CIK 0002113721 · CEO, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,609 F1 · shares: Represents two restricted stock unit ("RSU") grants, consisting of (i) 3,642 RSUs that are fully vested, and (ii) 10,000 RSUs, which vest in eight equal quarterly installments commencing on November 15, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.